Navigation Links
SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
Date:4/23/2009

San Diego, April 23 /PRNewswire-FirstCall/ -- SEQUENOM, Inc. (Nasdaq: SQNM), today announced that it will report first quarter 2009 financial results after market close on Thursday, April 30, 2009. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.

    Conference Call Information:
    Domestic callers: 1 (866) 844-2998
    International callers: 1 (706) 679-9912

Webcast information: Visit the investor relations section at www.sequenom.com.

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).

A webcast replay will be available on the SEQUENOM Web site for 14 days. A telephone replay will be available for 48 hours following the conclusion of the call by dialing (800) 642-1687 for domestic callers, or (706) 645-9291 for international callers, and entering reservation code 93862699.

About SEQUENOM

SEQUENOM is committed to providing the best genetic analysis products that translate the results of genomic science into solutions for noninvasive prenatal diagnostics, biomedical research, translational research and molecular medicine applications. The company's proprietary MassARRAY(R) system is a high-performance (in speed, accuracy and cost efficiency) nucleic acid analysis platform that quantitatively and precisely measures genetic target material and variations. The company has exclusively licensed intellectual property rights for the development and commercialization of noninvasive prenatal genetic tests for use with the MassARRAY system and other platforms. SEQUENOM maintains a website at www.sequenom.com to which SEQUENOM regularly posts copies of its press releases as well as additional information about SEQUENOM. Interested persons can subscribe on the SEQUENOM website to email alerts or RSS feeds that are sent automatically when SEQUENOM issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

SEQUENOM(R) and MassARRAY(R) are trademarks of SEQUENOM, Inc.

    Company Contact
    Ian Clements
    Sr. Director, Corp. Communications
    +1 (858) 202-9000

    Investor Relations Contact
    Lippert/Heilshorn & Associates
    Jody Cain (jcain@lhai.com)
    Kevin Mc Cabe (kmccabe@lhai.com)
    +1 (310) 691-7100

    Media Relations
    Pure Communications
    Sheryl Seapy
    +1 (949) 608-0841


'/>"/>
SOURCE SEQUENOM, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
2. Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3
3. Sequenom to Webcast Analyst and Investor Briefing Presentation on September 24
4. SENOMYX, INC. FIRST QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR MAY 7, 2009
5. Insmed to Host First Quarter 2009 Conference Call
6. Essilor : 2009 First Quarter Report
7. Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2009 Financial Results
8. Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
9. ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009
10. SiliconSky GPS Designs First AGPS-Enabled Asthma Inhaler for Landmark Research Program
11. Z Therapy Is The First In North Texas To Offer Revolutionary Treatment Option For Neck Pain Sufferers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... The report "Direct-Fed Microbials Market by Type (Lactic Acid Bacteria and Bacillus), Livestock (Pork/Swine, ... Forecast to 2022", published by MarketsandMarkets, the global market is estimated to be ... Million by 2022, at a CAGR of 6.96% from 2016. ... ... Logo ...
(Date:1/11/2017)... , ... January 11, 2017 , ... ... society for optics and photonics , are commending the U.S. Congress and President ... signing Friday by the President of the American Innovation and Competitiveness Act (AICA). ...
(Date:1/11/2017)... ... January 11, 2017 , ... ... cellular response analysis platform to measure the proteomic function of individual cells in ... Innovation Research (SBIR) grant from the National Institute on Aging of the National ...
(Date:1/11/2017)... England , PITTSBURGH and BENGALURU, ... -- Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE ... Food and Drug Administration (FDA) has accepted Mylan,s biologics ... for filing through the 351(k) pathway. This product is ... to treat certain HER2-positive breast cancers. The anticipated FDA ...
Breaking Biology Technology:
(Date:12/12/2016)...  Researchers at Trinity College, Dublin, are opening ... the material with Silly Putty. The mixture (known as ... to sense pulse, blood pressure, respiration, and even ... The research team,s findings were published Thursday ... http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/7/2016)... -- BioCatch , the global leader in behavioral biometrics, ... grew to over 40 granted and pending patents. ... , , The Company,s IP ... System, Device, and Method Estimating Force Applied to a Touch Surface, ... costly hardware components needed to estimate the force and pressure applied to ...
(Date:12/6/2016)... -- Valencell , the leading innovator in performance ... third consecutive year of triple digit growth for its ... a 360 percent increase in companies who have acquired ... by sales of its wrist and ear Benchmark™ sensor ... for hearables for fitness and healthcare applications. ...
Breaking Biology News(10 mins):